Home Page
-
Celebrating recent appointments and promotions in the School of Medicine Basic Sciences
Congratulations to our School of Medicine Basic Sciences community members who were promoted or received new appointments from January to March 2024! These individuals significantly enrich our pursuit of pathbreaking research and contribute to the growth and success of our school. Read MoreApr. 4, 2024
-
Hinton lab maps structure of mitochondria at different life stages
Antentor Hinton Jr. spearheaded a collaboration with labs from across Vanderbilt University, the U.S., and Brazil to create 3D maps of mitochondria inside brown adipose tissue, which may help researchers identify potential therapies to treat metabolic ailments. Read MoreApr. 4, 2024
-
Chazin named senior associate dean of biomedical research education and training
Walter Chazin, Chancellor’s Chair in Medicine and professor of biochemistry and chemistry, has been named senior associate dean of biomedical research education and training. Kathleen Gould, Louise B. McGavock Chair, is stepping down from the role after 14 years with the BRET Office to return her focus to her research program in the department of cell and developmental biology. Read MoreMar. 28, 2024
-
Sean Davies awarded Scaling Success grant to develop small molecules with promise of protecting against cardiometabolic disease
Davies received a Scaling Success grant to advance research on NAPE-PLD activators—potential key players in fighting cardiometabolic diseases. The team’s innovative research could lead to breakthrough treatments. Read MoreMar. 28, 2024
-
Teams to create one-stop resource for human pancreatic data to foster diabetes research
Leading investigators in diabetes, pancreas and islet biology, and computational biology have received $12.5 million in two five-year awards from the National Institutes of Health to create the world’s first, integrated knowledge base of human-derived tissue- and cellular-level pancreatic information to support innovative, collaborative and reproducible research. Read MoreMar. 28, 2024
-
Vanderbilt biochemists contribute to breakthrough discovery of first new antibacterial class in decades
Led by Neil Osheroff, Vanderbilt researchers are the first to undertake a systematic analysis of the mechanism of action of geoptidacin. Gepotidacin is poised to become the first new class of antibacterials to be approved for use in humans in decades. Read MoreMar. 26, 2024
-
Jay Jerome honored by Microscopy Society of America
Jerome is the 2024 recipient of the Distinguished Scientist Award, which honors “preeminent senior scientists for a long-standing record of achievement in the field of microscopy and microanalysis.” Read MoreMar. 26, 2024
-
Calipari launches AUD Research and Education Center with prestigious $8.9 million NIH grant
An $8.9 million grant from the NIH will establish the Vanderbilt AUD Research and Education Center, enhancing Vanderbilt University’s national leadership in neuroscience and addiction research. This initiative aims to foster interdisciplinary collaboration, advance understanding and treatment of alcohol use disorder, and engage the public through education and outreach efforts. Read MoreMar. 21, 2024
-
Taking a Bite Out of Charcot-Marie-Tooth Disease
“You’re nervous because you don't know what to expect and excited to see whatever it is you get to see,” Schlafly said of the visit. "I had seen a lab before, but I must say, it’s a pretty humbling experience to go from thinking there is no one at all who knows about your really weird, rare disease to walking into a lab and learning that everyone there is in some way working to cure my issue.” Read MoreMar. 18, 2024
-
Vanderbilt basic scientists receive National Science Foundation grant to explore RNA behavior
Manuel Ascano and Alissa Weaver are one of nine research teams to receive funding to understand the potential biotechnological uses of RNA more fully. The research is expected to provide opportunities to partner with industry to translate knowledge gained in the laboratory into marketable new therapeutics. Read MoreMar. 18, 2024